Tert-butyl (4S)-4-[3-[[(S)-tert-butylsulfinyl]amino]-3-pyridin-2-ylpropyl]-2,2-dimethylpyrrolidine-1-carboxylate
C23H39N3O3S — CID 156639202
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tert-butyl (4S)-4-[3-[[(S)-tert-butylsulfinyl]amino]-3-pyridin-2-ylpropyl]-2,2-dimethylpyrrolidine-1-carboxylate
Tert-butyl (4S)-4-[3-[[(S)-tert-butylsulfinyl]amino]-3-pyridin-2-ylpropyl]-2,2-dimethylpyrrolidine-1-carboxylate (PubChem CID 156639202) has the molecular formula C23H39N3O3S and a molecular weight of 437.65 g/mol. Its IUPAC name is tert-butyl (4S)-4-[3-[[(S)-tert-butylsulfinyl]amino]-3-pyridin-2-ylpropyl]-2,2-dimethylpyrrolidine-1-carboxylate.
Molecular Properties
| Compound Name | Tert-butyl (4S)-4-[3-[[(S)-tert-butylsulfinyl]amino]-3-pyridin-2-ylpropyl]-2,2-dimethylpyrrolidine-1-carboxylate |
|---|---|
| PubChem CID | 156639202 |
| Molecular Formula | C23H39N3O3S |
| Molecular Weight | 437.65 g/mol |
| Exact Mass | 437.27 |
| IUPAC Name | tert-butyl (4S)-4-[3-[[(S)-tert-butylsulfinyl]amino]-3-pyridin-2-ylpropyl]-2,2-dimethylpyrrolidine-1-carboxylate |
| SMILES | CC(C)(C)OC(=O)N1C[C@@H](CCC(N[S@@](=O)C(C)(C)C)c2ccccn2)CC1(C)C |
| InChI | InChI=1S/C23H39N3O3S/c1-21(2,3)29-20(27)26-16-17(15-23(26,7)8)12-13-19(18-11-9-10-14-24-18)25-30(28)22(4,5)6/h9-11,14,17,19,25H,12-13,15-16H2,1-8H3/t17-,19?,30-/m0/s1 |
| InChIKey | UTXVMENQORJDSE-LJMKLUPOSA-N |
| XLogP | 4.99 |
| TPSA | 71.53 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 437.65 |
| LogP ≤ 5 | 4.99 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156639202 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.